Thermo Fisher Scientific, NYSE: – Investing.com reported Thursday the results of their first quarter. They beat analyst forecasts with a revenue increase that exceeded expectations.

Thermo Fisher Scientific posted earnings per share in the range of $7.25 to $11.82B on revenue. Investing.com polled analysts and predicted EPS at $6.22 for revenue $10.7B.

Thermo Fisher Scientific shares have fallen 22% since the start of the year. However, they are still 22.59% below their 52-week high of $672.34 on December 31, 2021. They are under-performing the S&P 500 which is down 12.22% from the start of the year.

Thermo Fisher Scientific is following other notable Healthcare sector earnings in this month

Thermo Fisher Scientific reports on UnitedHealth’s earnings beat on April 14. UnitedHealth reported EPS at $5.49 for revenue $80.15B. This compares to the forecasts of EPS at $5.36 for revenue $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar